Relative bioavailability and safety study of pasireotide after a single-dose subcutaneous administration in the arm or in the thigh compared to in the abdomen using a ServoPen in healthy subjects.
SOM230-RECAG-PK-612
Phase 1 other active
Quick answer
Relative bioavailability and safety study of pasireotide after a single-dose subcutaneous administration in the arm or in the thigh compared to in the abdomen using a ServoPen in healthy subjects. for Post-bariatric hypoglycaemia is a Phase 1 program (other) at Recordati Ireland with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Recordati Ireland
- Indication
- Post-bariatric hypoglycaemia
- Phase
- Phase 1
- Modality
- other
- Status
- active